PubChem CID 16119086 Formula C18H24F2N2O 3D model (Jmol) Interactive image | ChemSpider 25069700 Molar mass 322.392 | |
 | ||
PF-03654746 is a potent and selective histamine H3 receptor antagonist developed by Pfizer and currently undergoing clinical trials for the treatment of ADHD, Tourette syndrome as well as potential anti-allergy applications.
References
PF-03654746 Wikipedia(Text) CC BY-SA